These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9742500)

  • 1. Treatment of hepatocellular carcinoma: medical options.
    Fried MW
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S92-7. PubMed ID: 9742500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
    Allgaier HP; Rossi S; Deibert P; Zuber I; Hering M; Blum HE
    Praxis (Bern 1994); 2000 Jun; 89(24):1056-60. PubMed ID: 10902462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
    Wakabayashi H; Ushiyama T; Ishimura K; Izuishi K; Karasawa Y; Masaki T; Watanabe S; Kuriyama S; Maeta H
    J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-directed treatment modalities for primary and secondary hepatic tumors.
    Yamane B; Weber S
    Surg Clin North Am; 2009 Feb; 89(1):97-113, ix. PubMed ID: 19186233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsurgical treatment of hepatocellular carcinoma.
    Llovet JM; Sala M; Bruix J
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoembolization and bland embolization: a critical appraisal.
    Befeler AS
    Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advanced hepatocellular carcinoma: therapeutic results in 110 patients and therapeutic strategy].
    Inoue Y; Ishida T; Murakami T; Nakamura H
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1857-64. PubMed ID: 9797808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative techniques for hepatic cancer.
    Ruan DT; Warren RS
    Surg Oncol Clin N Am; 2004 Jul; 13(3):505-16, ix. PubMed ID: 15236732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nonsurgical therapy of focal liver lesions].
    Allgaier HP; Deibert P; Blum HE
    Praxis (Bern 1994); 1997 Jan; 86(4):86-90. PubMed ID: 9064724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nonsurgical therapy methods in hepatocellular carcinoma].
    Wettstein M; Häussinger D
    Praxis (Bern 1994); 2001 Jan; 90(1-2):15-20. PubMed ID: 11206095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatocellular carcinoma: npn-surgical treatment].
    Allgaier HP; Deibert P; Becker G; Blum HE
    Praxis (Bern 1994); 1998 Oct; 87(44):1466-70. PubMed ID: 9847686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma: multimodality management.
    Christians KK; Pitt HA; Rilling WS; Franco J; Quiroz FA; Adams MB; Wallace JR; Quebbeman EJ
    Surgery; 2001 Oct; 130(4):554-9; discussion 559-60. PubMed ID: 11602884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New therapeutic options in the treatment of hepatocellular carcinoma].
    Martinotti R; Evangelista W; Goss M; Angelini F; Satolli MA
    Minerva Med; 2001 Oct; 92(5):341-7. PubMed ID: 11675578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality management of hepatocellular carcinoma larger than 10 cm.
    Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
    J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multimodal therapy concepts in hepatocellular carcinoma].
    Bismuth H
    Zentralbl Chir; 2000; 125(7):647-9. PubMed ID: 10960977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.